Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

HCV enters the twenty-first century.

Brar I, Baxa D, Markowitz N.

Curr Infect Dis Rep. 2013 Feb;15(1):52-60. doi: 10.1007/s11908-012-0313-1.

PMID:
23263749
3.

A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.

Murata M, Furusyo N, Ogawa E, Mitsumoto F, Hiramine S, Ikezaki H, Takayama K, Shimizu M, Toyoda K, Kainuma M, Hayashi J.

J Infect Chemother. 2014 May;20(5):320-4. doi: 10.1016/j.jiac.2013.11.006. Epub 2014 Jan 27.

PMID:
24477330
4.

Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.

Beste LA, Green PK, Ioannou GN.

Eur J Gastroenterol Hepatol. 2015 Feb;27(2):123-9. doi: 10.1097/MEG.0000000000000241.

PMID:
25503739
5.

Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office.

Tien PC; Veterans Affairs Hepatitis C Resource Center Program; National Hepatitis C Program Office.

Am J Gastroenterol. 2005 Oct;100(10):2338-54. Erratum in: Am J Gastroenterol. 2005 Nov;100(11):2609.

PMID:
16181388
6.
7.

Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Naggie S, Sulkowski MS.

Gastroenterology. 2012 May;142(6):1324-1334.e3. doi: 10.1053/j.gastro.2012.02.012. Review.

8.

Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.

Aherfi S, Solas C, Motte A, Moreau J, Borentain P, Mokhtari S, Botta-Fridlund D, Dhiver C, Portal I, Ruiz JM, Ravaux I, Bregigeon S, Poizot-Martin I, Stein A, Gérolami R, Brouqui P, Tamalet C, Colson P.

J Med Virol. 2014 Nov;86(11):1868-76. doi: 10.1002/jmv.24016. Epub 2014 Jul 23.

PMID:
25052594
9.

Current management of hepatitis C virus infection in patients with HIV co-infection.

Sulkowski MS.

J Infect Dis. 2013 Mar;207 Suppl 1:S26-32. doi: 10.1093/infdis/jis764.

10.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516.

PMID:
25387314
11.

Treatment of hepatitis C in HIV-coinfected patients.

Hughes CA, Shafran SD.

Ann Pharmacother. 2006 Mar;40(3):479-89; quiz 582-3. Epub 2006 Feb 28. Review.

PMID:
16507622
12.

Treatment of chronic hepatitis C in patients with HIV/HCV coinfection.

Coppola N, Martini S, Pisaturo M, Sagnelli C, Filippini P, Sagnelli E.

World J Virol. 2015 Feb 12;4(1):1-12. doi: 10.5501/wjv.v4.i1.1. Review.

13.

Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection.

Naqvi A, Giordanengo V, Dunais B, de Salvador-Guillouet F, Perbost I, Durant J, Pugliese P, Joulié A, Roger PM, Rosenthal E.

World J Hepatol. 2015 Aug 28;7(18):2177-83. doi: 10.4254/wjh.v7.i18.2177.

14.

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.

Zylberberg H, Benhamou Y, Lagneaux JL, Landau A, Chaix ML, Fontaine H, Bochet M, Poynard T, Katlama C, Pialoux G, Bréchot C, Pol S.

Gut. 2000 Nov;47(5):694-7.

15.

[Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection].

Macías J, Rivero A.

Enferm Infecc Microbiol Clin. 2013 Jul;31 Suppl 3:33-6. doi: 10.1016/S0213-005X(13)70122-8. Review. Spanish.

PMID:
24063901
16.

The treatment of chronic hepatitis C virus infection in HIV co-infection.

Vogel M, Rockstroh JK.

Eur J Med Res. 2009;14:507-15. Review.

17.

Hepatitis C virus-human immunodeficiency virus coinfection.

Sulkowski MS.

Liver Int. 2012 Feb;32 Suppl 1:129-34. doi: 10.1111/j.1478-3231.2011.02719.x. Review.

PMID:
22212583
18.

Management of HIV and hepatitis virus coinfection.

Mendes-Corrêa M, Núñez M.

Expert Opin Pharmacother. 2010 Oct;11(15):2497-516. doi: 10.1517/14656566.2010.500615. Review.

PMID:
20629586
19.

A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.

Chen EY, Sclair SN, Czul F, Apica B, Dubin P, Martin P, Lee WM.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1014-20.e1-2. doi: 10.1016/j.cgh.2013.03.032. Epub 2013 Apr 16.

PMID:
23602817
20.

Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.

Fierer DS, Dieterich DT, Mullen MP, Branch AD, Uriel AJ, Carriero DC, van Seggelen WO, Hijdra RM, Cassagnol DG; New York Acute Hepatitis C Surveillance Network.

Clin Infect Dis. 2014 Mar;58(6):873-9. doi: 10.1093/cid/cit799. Epub 2013 Dec 13.

Supplemental Content

Support Center